Scuoppo, C., Ramirez, R., Leong, S. F., Koester, M., Mattes, Z. F., Mendelson, K., . . . Rotolo, J. A. The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses. Frontiers Media S.A.
Chicago Style (17th ed.) CitationScuoppo, Claudio, et al. The C/EBPβ Antagonist Peptide Lucicebtide (ST101) Induces Macrophage Polarization Toward a Pro-inflammatory Phenotype and Enhances Anti-tumor Immune Responses. Frontiers Media S.A.
MLA (9th ed.) CitationScuoppo, Claudio, et al. The C/EBPβ Antagonist Peptide Lucicebtide (ST101) Induces Macrophage Polarization Toward a Pro-inflammatory Phenotype and Enhances Anti-tumor Immune Responses. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.